spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 5


Fig. 5. Ndst1 mutation disrupted Fgf10/Fgfr2b interaction and ectopic lacrimal gland budding. (A-F) LACE assay of FGF/FGFR binding at the lacrimal gland buds. Heparan sulfate mediated Fgf10/Fgfr2b and Fgf7/Fgfr2b binding were observed in the tip of wild-type lacrimal gland buds, but not in that of the Ndst1flox/flox;Le-Cre mutant embryos (arrow). By contrast, ubiquitous Fgf1/Fgfr2b was present in both wild-type and mutant embryos (arrowheads). (G-L) Ectopic lacrimal gland budding induced by Fgf10. The control explant developed endogenous lacrimal gland in the presence of BSA-containing beads (G, asterisks). By contrast, Fgf10 beads induced additional ectopic lacrimal gland buds in both control and Ndst1flox/flox;Le-Cre explants (J,K, arrowheads), whereas no buds appeared in the Ndst1/2 double mutants (I,L). (M) Lacrimal budding rate in explant cultures [Fisher's exact test: endogenous budding in control and Ndst1flox/flox;Le-Cre mutants, P<0.001; ectopic budding in control and Ndst1/2 double mutants (Ndst1flox/flox;Ndst2-/-;Le-Cre), P<0.02].





Right arrow Return to article